logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Huang He 封面图

Huang He｜He Huang

zhejiang university school of medicine教授邮箱:huanghe@zju.edu.cn
H指数:67
被引数:2.1万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Benefit of haploidentical hematopoietic stem cell transplantation for elderly patients with acute myeloid leukemia in first complete remission: A clinical observational study with in-depth time-dependent analysis

异基因造血干细胞移植对处于首次完全缓解期的老年急性髓系白血病患者的益处：一项具有深入时间依赖性分析的临床观察性研究

Therapeutic Advances in Hematology
IF3.1
2026-10-130
PRE
Bingqian Jiang; Haifei Guo; Na Tao; Yanmin Zhao; Yi Luo; Jian Yu; Huarui Fu; Xiaoyu Lai; Lizhen Liu; Yishan Ye; Weiyan Zheng; Jie Sun; Jingsong He; Yi Zhao; Guoqing Wei; Zhen Cai; He Huang; Jimin Shi
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia

TIM3靶向递送venetoclax克服药物耐药性并重新激活急性髓系白血病中的NK细胞活性

Nature Cancer
IF28.5
2026-08-120
PRE
Qiwei Wang; Jingyi Li; Xin Zeng; Lina Liu; Huan Lu; Yin Zhao; Yan Huang; Rui Wang; Chen Wang; Yingli Han; Yishan Ye; Yanmin Zhao; Jimin Shi; Yi Luo; Weiyan Zheng; Yongxian Hu; Shibing Wang; Xiangmin Tong; He Huang; Shanshan Pei; Pengxu Qian
Low-dose chidamide maintenance therapy following allogeneic hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia or lymphomas: a phase II, open-label, multicenter, single-arm trial

低剂量沙利度胺维持治疗在T细胞急性淋巴细胞白血病或淋巴瘤异基因造血细胞移植后的应用：一项II期、开放标签、多中心、单臂试验

Lancet Regional Health-Western Pacific
IF8.1
2026-07-010
OAAI
Zhao, Yanmin; Chen, Weihao; Yu, Yi; Luo, Yi; Yu, Jian; Fu, Huarui; Lai, Xiaoyu; Liu, Lizhen; Ouyang, Guifang; Shi, Jimin; Sheng, Lixia; Cao, Weijie; Huang, He
Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT

移植前后TP53分子微小残留病作为TP53突变AML/MDS接受异基因造血干细胞移植患者复发的预后生物标志物

Blood Cancer Journal
IF11.6
2026-06-260
OAAI
Yeqian Zhao; Weijie Cao; Jimin Shi; Yiqiu Zheng; Yi Luo; Jian Yu; Lizhen Liu; Xiaoyu Lai; Huarui Fu; Congxiao Zhang; Yi Yu; Yishan Ye; Jiehan Liang; Xin Huang; Yang Cao; Wei Shi; Xiaoxia Hu; He Huang; Yanmin Zhao
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial

将维奈克拉纳入50岁及以上急性髓系白血病和骨髓增生异常综合征患者氟达拉滨联合美法仑预处理方案中的整合：一项II期临床试验结果

Cancer
IF5.1
2026-05-200
PRE
Xiaoyu Lai PhD; Panpan Zhu MD; Luxin Yang MD; Lizhen Liu PhD; Yibo Wu MD; Jimin Shi MD; Jian Yu PhD; Yanmin Zhao PhD; Guifang Ouyang MD; Yi Chen MD; Yishan Ye MD; Ping Zhang MD; Lan Sun MD; Weiyan Zheng MD; Jie Sun PhD; He Huang MD, PhD; Yi Luo MD, PhD
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up

移植前微小残留病阴性及年龄小于40岁预测CAR-T治疗后复发/难治性B-ALL行半相合造血干细胞移植桥接治疗患者的长期生存优势：一项随访6年的多中心回顾性研究

American Journal of Hematology
IF9.9
2026-05-130
PRE
Houli Zhao; Zhouning Lin; Haiqiong Zheng; Guoqing Wei; Yi Luo; Jimin Shi; Qu Cui; Mingfeng Zhao; Aibin Liang; Qing Zhang; Jianmin Yang; Xin Li; Jing Chen; Xianmin Song; Hongmei Jing; Yuhua Li; Siguo Hao; Wenjun Wu; Elaine Tan Su Yin; Yamin Tan; Jian Yu; Yanmin Zhao; Xiaoyu Lai; Yunxiong Wei; Ping Li; Jing Huang; Tao Wang; Didier Blaise; Lei Xiao; Alex H. Chang; Arnon Nagler; Garret Leung; Mohamad Mohty; He Huang; Yongxian Hu
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study

亚洲成人HSCT受者TA-TMA风险分层和新预后生物标志物的验证：一项多中心真实世界研究

Bone Marrow Transplantation
IF5.2
2026-01-090
PRE
Yibo Wu; Xiaolin Yuan; Lieguang Chen; Xiaoyu Lai; Lizhen Liu; Luxin Yang; Jimin Shi; Jian Yu; Yanmin Zhao; Guifang Ouyang; Lihong Ni; Haowen Xiao; Yang Xu; Li Tang; Panpan Zhu; Zhen Cai; He Huang; Ying Lu; Yi Luo
Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy

基线18F-FDG PET/CT对BCMA CAR T细胞治疗后复发或难治性多发性骨髓瘤患者毒性和预后的预测价值

Bone Marrow Transplantation
IF5.2
2025-12-130
PRE
Pingnan Xiao; Xin Zhao; Linqin Wang; Kanfeng Liu; Yixue Li; Mingming Zhang; Yafei Zhang; Yinuo Liu; Jingjing Feng; Ruimin Hong; Shan Fu; Houli Zhao; Jiazhen Cui; Huijun Xu; Xiaoyu Wu; Yanlei Zhang; Guoqing Wei; Alex Hongsheng Chang; Kui Zhao; He Huang; Yongxian Hu

研究方向

Clinical and basic research on hematopoietic stem cell transplantationMolecular biology and precision treatment of hematological diseaseCellular immunotherapyStem cell biology research
Y
Yi Luo
H 指数:28论文数:347被引数:3,542
Y
Yanmin Zhao
H 指数:28论文数:277被引数:2,831
J
Jimin Shi
H 指数:27论文数:294被引数:2,871
Y
Yongxian Hu
H 指数:30论文数:266被引数:3,380
X
Xiaoyu Lai
H 指数:24论文数:245被引数:2,196
L
Lizhen Liu
H 指数:28论文数:394被引数:4,472
P
Pengxu Qian
H 指数:40论文数:188被引数:6,194
J
Jian Yu
H 指数:24论文数:167被引数:1,917
Y
Yamin Tan
H 指数:23论文数:186被引数:1,747
G
Guoqing Wei
H 指数:28论文数:203被引数:5,771